Intellect Neurosciences, Inc. Issues Letter to Shareholders
March 19, 2015 07:30 ET
|
Intellect Neurosciences, Inc.
NEW YORK, March 19, 2015 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCPNK:ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic and...
Intellect Neurosciences, Inc. Issues Letter to Shareholders
September 24, 2014 08:00 ET
|
Intellect Neurosciences, Inc.
NEW YORK, Sept. 24, 2014 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCPNK:ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents...
Intellect Neurosciences, Inc. Issues Letter to Shareholders
August 13, 2014 08:00 ET
|
Intellect Neurosciences, Inc.
NEW YORK, Aug. 13, 2014 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCPK:ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for...
Intellect Neurosciences, Inc. Issues Letter to Shareholders
July 31, 2014 08:00 ET
|
Intellect Neurosciences, Inc.
NEW YORK, July 31, 2014 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCPNK:ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents...
Intellect Neurosciences Obtains Patent Allowance From the United States Patent and Trademark Office in Relation to Its TOC-1 Monoclonal Antibody Selective for Pre-Fibrillar Tau Aggregates
November 14, 2013 14:15 ET
|
Intellect Neurosciences, Inc.
NEW YORK, Nov. 14, 2013 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic and...
Intellect Neurosciences Retains Chain Pharmaceuticals LLC
July 30, 2013 11:30 ET
|
Intellect Neurosciences, Inc.
NEW YORK, July 30, 2013 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS) announced today it has retained Chain Pharmaceuticals LLC as a consultant to assist the company in managing its...
Intellect Neurosciences, Inc. Issues Letter to Shareholders
June 20, 2013 09:25 ET
|
Intellect Neurosciences, Inc.
NEW YORK, June 20, 2013 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company engaged in the discovery and development of treatments for the prevention and...
Intellect Neurosciences Engages Evli Corporate Finance to Explore Strategic Alternatives to Maximize Shareholder Value
June 18, 2013 11:31 ET
|
Intellect Neurosciences, Inc.
NEW YORK, June 18, 2013 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company engaged in the discovery and development of treatments for the prevention and...
Intellect Neurosciences Issues Letter to Shareholders
March 29, 2013 09:35 ET
|
Intellect Neurosciences, Inc.
NEW YORK, March 29, 2013 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company engaged in the discovery and development of treatments for the prevention and...
Intellect Neurosciences to Present at Bio-Europe Spring Conference in Barcelona
February 28, 2013 09:35 ET
|
Intellect Neurosciences, Inc.
NEW YORK, Feb. 28, 2013 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS) announces Dr. Daniel G. Chain, Chairman and CEO, will present at the Bio-Europe Spring Conference March 11-13,...